Furthermore, regarding irisin (overall p for trend p < 0.01) treatment-naïve cancer group patients exhibited higher Ln-transformed irisin levels compared to healthy controls (p < 0.01) (Figure 1(b)). The gene discussed is FNDC5; the disease is cancer.